Dayong Shi Selected Research

bis(diazo)benzidine (BDB)

10/2020	Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides.
9/2020	16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dayong Shi Research Topics

Disease

10	Neoplasms (Cancer) 03/2022 - 12/2015
6	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2018
5	Insulin Resistance 05/2020 - 07/2015
3	Obesity 10/2020 - 03/2019
3	Dyslipidemias (Dyslipidemia) 01/2019 - 01/2018
2	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 12/2015
1	Metabolic Diseases (Metabolic Disease) 10/2020
1	Breast Neoplasms (Breast Cancer) 02/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019
1	Carcinogenesis 11/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2019
1	Hyperglycemia 01/2019
1	Hypoxia (Hypoxemia) 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 02/2015

Drug/Important Bio-Agent (IBA)

4	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2021 - 01/2019
4	Biological ProductsIBA 09/2019 - 01/2019
3	Pharmaceutical PreparationsIBA 03/2022 - 11/2018
3	Protein Tyrosine PhosphatasesIBA 10/2020 - 01/2019
3	Insulin (Novolin)FDA Link 03/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2019
2	bis(diazo)benzidine (BDB)IBA 10/2020 - 09/2020
2	PalmitatesIBA 05/2020 - 01/2018
2	ThiosemicarbazonesIBA 01/2019 - 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2021
1	dipeptidaseIBA 01/2021
1	16S Ribosomal RNAIBA 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2020
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 02/2020
1	Small Interfering RNA (siRNA)IBA 11/2019
1	Eukaryotic Initiation Factor-4EIBA 09/2019
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 09/2019
1	Peptide Initiation Factors (Initiation Factor)IBA 09/2019
1	Caspase 3 (Caspase-3)IBA 05/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2019
1	diphenyl (biphenyl)IBA 04/2019
1	BromidesIBA 04/2019
1	Glucose (Dextrose)FDA LinkGeneric 03/2019
1	CholesterolIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 11/2018
1	OxidesIBA 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	ZincIBA 01/2018
1	CopperIBA 01/2018
1	Temozolomide (Temodar)FDA LinkGeneric 01/2018
1	CarbohydratesIBA 01/2017
1	hydrazinecarbothioamideIBA 01/2017
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2017
1	cardamoninIBA 12/2015
1	N-(gamma-maleimidobutyryloxy)succinimide (GMBS)IBA 12/2015
1	LipidsIBA 07/2015
1	IntegrinsIBA 02/2015

Therapy/Procedure

3	Oral Administration 03/2019 - 01/2018
2	Therapeutics 01/2018 - 01/2018
1	Drug Therapy (Chemotherapy) 12/2015